Usefulness of serotoninergic challenge with oral citalopram

Revista Brasileira de Psiquiatria

Volumn 28, Issue 3, 2006, Pages 203-205

  Mattos, Paulo ^a,b   Franco, Vanessa A ^a   Noel, François ^a   Segenreich, Daniel ^a   Gonçalves, José Carlos ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Challenge; Citalopram; Cortisol; GH; Prolactin

Indexed keywords

CITALOPRAM; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PROLACTIN BLOOD LEVEL; PROVOCATION TEST; SEROTONINERGIC SYSTEM;

EID: 33749401805     PISSN: 15164446     EISSN: 15164446     Source Type: Journal    
DOI: 10.1590/S1516-44462006000300011     Document Type: Article

References (15)

1. Aberg-Wistedt A, Hasselmark L, Stain-Malmgren R, Aperia B, Kjellman BF, Mathe AA. Serotoninergic vulnerability in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders. Acta Psychiatr Scand. 1998;97(5):374-80.
2. Stoff DM, Pasatiempo AP, Yeung J, Cooper TB, Bridger WH, Rabinovich H. Neuroendocrine responses to challenge with dl-fenfluramine agression in disruptive behaviour disorders of children and adolescents. Psychiatry Res. 1992;43(3):263-76.
3. Snoek-Heddek A, Van-Goosen SH, Matthys W, Sigling HO, Koppeschaar HP, Westenberg HG, Van Engeland H. Serotoninergic functioning in children with oppositional defiant disorder: a sumatriptan challenge study. Biol Psychiatry. 2002;51(4):319-25.
4. Dolan M, Anderson IM, Deakin JF. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry. 2001;178:352-9.
5. Hanley NR, Van de Kar LD. Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary adrenal axis in health and disease. Vitam Horm. 2003;66:189-255.
6. Van de Kar LD, Urban JH, Richardson KD, Bethea CL. Pharmacological studies on the serotoninergic and non-serotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pre-treatment with fluoxetine, indalpine, PCPA, and L-tryptophan. Neuroendocrinology. 1985;41:283-8.
7. Seifritz E, Baumann P, Muller MJ, Annen O, Amey M, Hemmeter U, Hatzinger M, Chardon F, Holsboer-Trachsler E. Neuroendocrine Effects of a 20-mg Citalopram Infusion in Healthy Males. Neuropsychopharmacology 1996;14(4):253-63.
8. Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ. Low-dose Citalopram as a 5-HT neuroendocrine probe. Psychopharmacology (Berl). 2001;155(3):323-6.
9. Mueller EA, Murphy DL, Sunderland T. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology (Berl). 1986;89(3):388-91.
10. Nadeem HS, Attenburrow Mj, Cowen PJ. Comparison of the effects of citalopram and escitalopram on 5-HT mediated neuroendocrine response. Neuropsychopharmacology. 2004;29(9):1699-703.
11. McBride PA, Tierney H, DeMeo M, Chen JS, Mann JJ. Effects of age and gender on CNS serotoninergic responsivity in normal adults. Biol Psychiatry. 1990;27(10):1143-55.
12. Benton D. Carbohydrate ingestion, blood glucose and mood. Neuroscience Biobehav Rev. 2002;26(3):293-308.
13. Melmed S, Kleinberg D. Anterior Pituitary. In: Larsen PR, Kronenberg HM, Melmed S, Polansky KS, eds. Williams Textbook of Endocrinology. New York: Saunders; 2003. p. 177-279.
14. van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996;81(7):2468-73.
15. Hennig J, Netter P. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests. Int J Neuropsychopharmacology. 2002;5(1):67-71.